Comparing Insulin Therapies for Type 2 Diabetes
Author Information
Author(s): Miyashita Yumi, Nishimura Rimei, Nemoto Masami, Matsudaira Toru, Kurata Hideaki, Yokota Tamotsu, Yokota Kuninobu, Tojo Katsuyoshi, Utsunomiya Kazunori, Tajima Naoko
Primary Institution: Jikei University School of Medicine
Hypothesis
Can a twice-daily biphasic insulin analogue provide similar glycemic control as a basal-bolus insulin regimen in type 2 diabetic patients with secondary failure of sulfonylureas?
Conclusion
Both insulin therapies resulted in similar reductions in HbA1c, suggesting that basal-bolus therapy may not be necessary for these patients.
Supporting Evidence
- HbA1c was significantly reduced in both groups after 6 months.
- There was no significant difference in IMT between the two groups.
- The 30 Mix group showed a significant increase in insulin usage after treatment.
Takeaway
This study looked at two types of insulin treatments for diabetes and found that both worked equally well to lower blood sugar levels.
Methodology
42 type 2 diabetic patients were randomly assigned to either basal-bolus therapy or a biphasic insulin analogue for 6 months, measuring various health indicators.
Potential Biases
Potential bias in self-reported adherence to insulin therapy.
Limitations
The study duration of 6 months may not be sufficient to evaluate long-term effects on atherosclerosis.
Participant Demographics
Median age 64.5 years, 73.8% male.
Statistical Information
P-Value
p = 0.32
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website